Research & Grants
Scientific Research
Tower funds early-stage research, a crucial period for fostering discovery and innovation. It allows scientists and researchers to take risks and pursue new or unconventional ideas, creating the foundation for future breakthroughs.
Every funded researcher who goes on to publish, secure follow-on funding, or contribute to an FDA approval makes the field more visible and attractive to the next generation of scientists.
Tower isn’t just funding cancer research; it’s actively building the pipeline of people who will define it.
Backing the future of cancer research
Identifying promising research
Tower funds and supports high-risk, high-reward science. The only way to unlock more scientific breakthroughs is to back novel ideas.
Grant Applications
2026/2027 Grant Application Information
Submit your email below to be notified once the application window is released:
Scientific Advisory Board
Tower’s Scientific Advisory Board is comprised of leading scientists, physicians, researchers, and oncology experts who help identify the most promising early-stage cancer research projects for funding. Drawing from deep expertise across cancer treatment, science, and clinical research, the board evaluates bold ideas with the potential to drive meaningful breakthroughs in detection and treatment.
Most public and private funders are inherently risk-averse, leaving younger scientists with unconventional ideas underfunded when they need support most. Tower gets there first, funding early ideas and helping turn them into validated research that earns larger investment and recognition.
Without institutional bureaucracy, we can identify promising research, make decisions, and fund scientists quickly.
$12.1 million
to grant recipients
since 2016
29
unique grant
recipients since 2016
7
institutions funded
since 2016